FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, namely to mixture of E- and Z-isomers of (4-bromophenyl)ethylidene hydrazide of 2-[6-methyl-1-(thiethan-3-yl)uracyl-3-yl]acetic acid in molar ratio 3.5:1 of general formula: 
.
EFFECT: obtained is novel mixture of isomers, demonstrating hypotensive activity.
2 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 6-METHYL-1-(1-OXOTHIETAN-3-YL)URACIL, HAVING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2536683C1 |
| 6-METHYL-5-MORPHOLYNOMETHYL-1-(THIETHAN-3-YL)PYRIMIDINE-2,4(1H,3H)-DIONE, DEMONSTRATING ANTIOXIDANT ACTIVITY | 2013 |
|
RU2539302C1 |
| 5-BROMO-2-(THIETAN-3-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE DERIVATIVES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2011 |
|
RU2459818C1 |
| USE OF N'-{1-[6-METHYL-3-(TIETANE-3-YL)-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL]PROPAN-2-YLIDENE} ISONICOTINOHYDRAZIDE AS MEANS THAT STIMULATE TISSUE REGENERATION | 2023 |
|
RU2813148C1 |
| 1-(3-AMINOPROPYL)-3-HYDROXY-5-(4-FLUOROPHENYL)-4-(4-CHLOROBENZOYL)-3-PYRROLINE-2-ONE HYDROCHLORIDE ELICITING ANTI-INFLAMMATORY ACTIVITY | 2004 |
|
RU2259354C1 |
| METHOD FOR OPTIMISATION OF MEN CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY IN CASE OF ANDROGENODEFICIENCY WITH ARTERIAL HYPERTENSION | 2016 |
|
RU2632449C1 |
| 2-(1-(2-(2-CHLORO-10H-PHENOTHIAZIN-10-YL)-2-OXOETHYL)-5-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENOL, HAVING HYPOTENSIVE AND ANTIARRHYTHMIC ACTIVITY | 2008 |
|
RU2394823C2 |
| PROLONGED ANTIHYPERTENSION PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2012 |
|
RU2543637C2 |
| METHOD OF OPTIMIZATION OF TREATMENT OF WOMEN BY CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY FOR ESTROGENDEFICIENCY WITH HYPERTENSION IN THE LATE REPRODUCTIVE PERIOD | 2016 |
|
RU2648470C2 |
| 5-AMINO-SUBSTITUTED 3-BROMO-4-NITRO-1-(THIETAN-3-YL)-1H-PYRAZOLES EXHIBITING ANTIDEPRESSANT ACTIVITY | 2023 |
|
RU2817972C1 |
